Intravenous (IV) bortezomib infusion after non‐response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14032
Abstract: de Alba, E. (2009) Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). Journal of Biological Chemistry, 284, 32932–32941. Baharav, E., Bar, M., Taler, M., Gil-Ad, I., Karp, L., Weinberger, A. &… read more here.
Keywords: toll like; infusion non; intravenous bortezomib; bortezomib infusion ... See more keywords
Efficacy and safety of subcutaneous versus intravenous bortezomib in multiple myeloma: a meta-analysis .
Sign Up to like & getrecommendations! Published in 2017 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp202714
Abstract: PURPOSE We performed this meta-analysis to compare the efficacy and safety between two different administration routes of bortezomib, subcutaneous and intravenous. METHODS Six retrospective studies and three randomized controlled trials (RCTs) were included in our… read more here.
Keywords: efficacy safety; intravenous bortezomib; bortezomib; retrospective studies ... See more keywords